Home > PE Ratio > AJANTA PHARMA

AJANTA PHARMA
PE (Price/Earnings) Ratio

The Current P/E Ratio of AJANTA PHARMA is 37.36.

Share Price ₹2,183.3Mar 27,2024
Market Cap ₹27,487.7 Cr
Earnings-TTM₹735.7 CrTTM-Consolidated Results
Price/Earnings37.36xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results
AJANTA PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of AJANTA PHARMA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of AJANTA PHARMA is calculated as :

Current Market Cap [ ₹27,487.7 Cr] as on Mar 27,2024

(/) Earnings [ ₹735.7 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 37.36x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for AJANTA PHARMA , the investors are currently willing to pay 37.36 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AJANTA PHARMA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of AJANTA PHARMA over the last five years.

Historical PE (Price/Earnings) ratio chart of AJANTA PHARMA


PE Ratio Performance Analysis for AJANTA PHARMA

- AJANTA PHARMA 's latest p/e ratio is 37.36x.

- AJANTA PHARMA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 17.73x.

- AJANTA PHARMA 's operated at median p/e ratio of 15.82x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AJANTA PHARMA 's p/e ratio peaked in Mar2023 at 25.89x.

- AJANTA PHARMA 's p/e ratio hit its five-year low in Mar2022 of 14.45x.


How does AJANTA PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
AJANTA PHARMA 735.7037.3627,487.7
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6342.88385,837.0
DIVIS LABORATORIES LTD1,382.9764.5989,323.5
CIPLA LTD3,744.0331.62118,376.0
DR REDDYS LABORATORIES LTD5,209.4019.37100,885.0
TORRENT PHARMACEUTICALS LTD1,494.0058.0986,779.1
ABBOTT INDIA LTD1,145.5849.6256,838.6
ZYDUS LIFESCIENCES LTD2,954.2034.05100,583.0
ALKEM LABORATORIES LTD1,574.6637.9659,770.5
LUPIN LTD1,809.7440.2472,826.6
BIOCON LTD1,611.0019.1230,807.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs AJANTA PHARMA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.12x
Max industry PE 64.59x
Median industry PE 37.96x
Average industry PE 39.53x



You may also like the below Video Courses